PHIP
protein-codingpleckstrin homology domain interacting protein, the group of DDB1 and CUL4 associated factors|WD repeat domain containing|Bromodomain containing
Gene summary
This gene encodes a protein that binds to the insulin receptor substrate 1 protein and regulates glucose transporter translocation in skeletal muscle cells. The encoded protein may also regulate growth and survival of pancreatic beta cells. Elevated copy number of this gene may be associated with melanoma severity and the encoded protein may promote melanoma metastasis in human patients. [provided by RefSeq, Oct 2016]
- WDR11
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~143.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0060712
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0035133
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0035133
Submitter: ClinGen
The *PHIP* gene is located on chromosome 6q14.1 and encodes two-protein isoforms, PHIP/DCAF14 and NDRP. It was first reported in relation to autosomal dominant PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome in 2016 (Webster et al., 2016 PMID: 27900362). The most common features in individuals with *PHIP* variants include intellectual disability, overgrowth, behavioral problems, facial dysmorphism (high forehead, full eyebrows and/or snynophrys, large ears, upturned nose and/or thick alae nasi), and other features including visual problems, tapering fingers, clinodactyly fifth fingers, gastrointestinal problems. *PHIP* has been associated with the following disease entities: AD Chung-Jansen syndrome (MIM:617991, ORPHA:589905 ) and AD PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome (MONDO:0035133, ORPHA:589905). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity: PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome. The mechanism of pathogenicity is reported to be haploinsufficiency. Analysis suggests haploinsufficiency of PHIP/DCAF14, but not NDRP, is causative of the observed phenotype. At least 11 variants (4 missense and 7 nonsense/frameshift) that have been reported in 12 probands in 2 publications (PMIDs:29209020, 31167805 ) are included in this curation. Affected individuals typically harbor de novo, heterozygous loss-of-function and missense variants (PMID: 34773373). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. In summary, there is definitive evidence to support the relationship between *PHIP* and autosomal dominant PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 19, 2022 (SOP version 8).
Inheritance Pattern: AD
Disease ID:MONDO:0035133
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0035133
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0035133
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PHIP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017934.7. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 14 | 271 | 13 | 299 | |
| missense | 2 | 36 | 586 | 82 | 11 | 717 |
| nonsense | 29 | 33 | 8 | 70 | ||
| start loss | 1 | 2 | 3 | |||
| frameshift | 39 | 25 | 6 | 70 | ||
| splice donor/acceptor (+/-2bp) | 8 | 28 | 16 | 52 | ||
| Total | 79 | 123 | 632 | 353 | 24 | 1211 |
Highest pathogenic variant AF is 0.00048625233
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060404.4 | 40 | MANE Select | |
| Ensembl | ENSP00000275034.3 | 40 | MANE Select | |
| Ensembl | ENSP00000514753.1 | 18 | Standard | |
| Ensembl | ENSP00000514754.1 | 41 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of protein phosphorylation
- regulation of transcription by RNA polymerase II
- cytoskeleton organization
- positive regulation of cell population proliferation
- insulin receptor signaling pathway
Molecular Function
- insulin receptor binding
- protein binding
- lysine-acetylated histone binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000275034
- Coding exons
- 40
- Length
- 142370
- Individuals with no LoFs
- 125732
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 12
- Defined
- 125744
- p
- 0.0000477
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 5.14 | 508 | 955 | 0.532 | 0.0000497 | 11924 |
| Missense (PolyPhen) | 162 | 471.6 | 0.34351 | 5877 | ||
| Synonymous | 0.297 | 308 | 315 | 0.979 | 0.0000158 | 3388 |
| Loss of Function | 8.93 | 6 | 105 | 0.0574 | 0.00000608 | 1255 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000072 | 0.000070 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable regulator of the insulin and insulin-like growth factor signaling pathways. Stimulates cell proliferation through regulation of cyclin transcription and has an anti- apoptotic activity through AKT1 phosphorylation and activation. Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:12242307, ECO:0000269|PubMed:21834987}.;
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- LoFtool
- 0.444
- RVIS EVS
- -1.24
- RVIS percentile EVS
- 5.49
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.652
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |